Potential marker rhythms in multiple myeloma (notes on clinical chronobiology)
Tarquini, B.
Haematologica 64 Suppl: 50-61
1979
ISSN/ISBN: 0390-6078 PMID: 120284 Document Number: 142801
Document emailed within 1 workday
Related Documents
Brunschwig, H. 1988: Living rhythms of children affected by school rhythms. "Chronobiology to the aid of child rearing Soins. Gynecologie Obstetrique Puericulture Pediatrie 1988(85-86): 55-59Kanabrocki, E.L.; Ryan, M.D.; Murray, D.; Jacobs, R.W.; Wang, J.; Hurder, A.; Friedman, N.C.; Siegel, G.; Eladasari, B.; Nemchausky, B.A.; Cornelissen, G.; Halberg, F. 2006: Circadian variation in multiple sclerosis of oxidative stress marker of DNA damage. a potential cancer marker? La Clinica Terapeutica 157(2): 117-122
Poley, S.; Stieber, P.; Nüssler, V.; Pahl, H.; Fateh-Moghadam, A. 1997: Evaluation of serum neural cell adhesion molecule as a prognostic marker in multiple myeloma Anticancer Research 17(4b): 3021-3024
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Chanukuppa, V.; Taware, R.; Chatterjee, T.; Sharma, S.; More, T.H.; Taunk, K.; Kumar, S.; Santra, M.K.; Rapole, S. 2018: Current Understanding of the Potential of Proteomics and Metabolomics Approaches in Cancer Chemoresistance: A Focus on Multiple Myeloma Current Topics in Medicinal Chemistry 18(30): 2584-2598
Halberg, F. 1977: International Society for Chronobiology. President's letter: chronobiology in 1977 Chronobiologia 4(3): 255-263
Rubio Felix, D.; Giraldo, M.P.; Raichs, A.; García Zueco, J.C.; Mur, P.; Faura, M.V.; Ruíz-Marcuello, E.; Piñan, M.A. 1980: Therapy results and clinical course in 91 cases of multiple myeloma with regard to their clinical staging Sangre 25(1): 25-34
Torres, V.; Cerda, M.; Knaup, P.; Löpprich, M. 2016: Assessment of Automatically Exported Clinical Data from a Hospital Information System for Clinical Research in Multiple Myeloma Studies in Health Technology and Informatics 228: 332-336
Shimizu, K. 2007: Clinical features of multiple myeloma Nihon Rinsho. Japanese Journal of Clinical Medicine 65(12): 2218-2222
López Alvarez, J.; Sanz Marca, A.; Aboin Massieu, F.J. 1983: Multiple myeloma. Clinical review of 56 cases Revista Clinica Espanola 171(3): 175-178
Bataille, R. 1997: New insights in the clinical biology of multiple myeloma Seminars in Hematology 34(1 Suppl 1: 23-28
Hoering, A.; Crowley, J. 2007: Clinical trial designs for multiple myeloma Clinical Advances in Hematology and Oncology: H&o 5(4): 309-316
Kaur, P.; Shah, B.S.; Baja, P. 2014: Multiple myeloma: a clinical and pathological profile Gulf Journal of Oncology 1(16): 14-20
Varterasian, M.L. 1995: Biologic and clinical advances in multiple myeloma Oncology 9(5): 417
Vivaldi, P.; Comotti, C.; Pedrazzoli, M. 1994: The kidney in multiple myeloma. the physiopathological and clinical aspects Recenti Progressi in Medicina 85(2): 123-133
Pasqualetti, P.; Casale, R.; Colantonio, D. 1988: Clinical staging of multiple myeloma. Comparison of 7 different systems Giornale di Clinica Medica 69(12): 741-750
Paule, B.; Clerc, D.; Brion, N. 1998: Glucocorticoids and multiple myeloma. Mechanism of action, resistance and clinical use Annales de Medecine Interne 149(8): 502-507
Cristoffanini, A.P.; Vidal, M.A.; Cea, X.; Zapata, C. 1987: Multiple myeloma. Clinical experience of 15 years in the 10th region Revista Medica de Chile 115(11): 1061-1065
Stellingworth, M.; Broussard, A.; Cataldo, V.; Morrissey, J.Rene.; Lipscomb, G.; Lopez, F.A.; Rigby, P. 2003: Clinical case of the month. Weakness in an 88-year-old man. Multiple myeloma Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 155(2): 84-9; Quiz 89-90 119
Goranov, S. 1994: Clinical problems of infectious complications in patients with multiple myeloma Folia Medica 36(1): 41-46